Bob became the 1,000th volunteer to join the READ-OUT trial, having attended ReMind UK with concerns about his memory. After being diagnosed with mild cognitive impairment (MCI), he chose to take part in the READ-OUT trial, a major national dementia research study exploring whether blood tests could help diagnose dementia earlier and more accurately. This important milestone shows the difference people can make by taking part in clinical research. The study is undertaking broad, nationwide blood sampling at 33 sites across the UK, including here at ReMind UK, to understand which biomarkers perform the best in diagnosing Alzheimer’s and non-Alzheimer’s dementias.
Reaching 1,000 participants is a fantastic achievement and reflects the generosity of people like Bob, who are willing to take part in research that could transform dementia diagnosis for future generations. Clinical trials are only possible because of our volunteers, and every participant brings us one step closer to earlier diagnosis, better treatments and improved outcomes for people affected by dementia."
Dr Tomas Welsh; ReMind UK Research & Medical Director
Bob hopes that by sharing his story, more people will feel confident seeking help for memory concerns and consider taking part in research. Bob highlights, “What’s the point in sitting back and doing nothing? Research is vital to improving diagnosis, treatment and future care for people with Alzheimer’s disease, and I’m keen to help in any way I can.”
Memory Services at ReMind UK
At ReMind UK, we are proud to provide NHS memory services while leading pioneering dementia research that has the potential to change lives. Every clinical trial depends on people like Bob who are prepared to take part, but it also depends on charitable support to make that research possible.
Research Institute for Brain Health
ReMind UK aims to enable anyone wanting to take part in dementia research to enter a project which works for them. We are one of the few centres in the country with the level of expertise and required facilities to lead phase one and phase two novel treatment studies. Our staff are highly trained to care for older people and have the skills and experience needed to safely and efficiently manage treatment procedures, and over-night stays, putting those with a diagnosis first and in the best hands.
You can help dementia research
Register your interest to take part in a study or clinical trial
More news & views

Jon Snow’s story highlights the importance of talking about Alzheimer’s
Broadcaster Jon Snow has spoken publicly about living with Alzheimer’s disease, sharing his diagnosis in the hope of raising awareness and reducing stigma around dementia. Jon Snow’s experience of living with Alzheimer’s will be explored in a powerful new documentary, Jon Snow: A Last Big Story, produced by Basement Films and airing on Channel 4 on Saturday, 20 June 2026

Volunteers at the heart of ReMind UK: celebrating volunteers’ week
Volunteering is about more than giving time, it’s about creating connections, spreading kindness and helping build a stronger, more supportive community. Thanks to our volunteers, we are able to continue providing vital services and support to those who need it most.

How vision loss may contribute to dementia
When was the last time you attended for an eye test? Was it due to having symptoms you were concerned about, or for a routine check-up? Would your attendance for eye checks alter if you knew that untreated vision loss is now thought to be a potentially modifiable risk factor for dementia? This month we explore untreated vision loss as a potentially modifiable risk factor for dementia.